Yes, RxSight Inc. is a fully public commercial-stage medical technology corporation traded on the Nasdaq stock exchange under the ticker symbol RXST. The company successfully launched its initial public offering to raise capital for the research, development, manufacturing, and global commercialization of its proprietary ophthalmic products, most notably the Light Adjustable Lens and the accompanying Light Delivery Device system. Being a publicly listed entity on a major U.S. stock exchange means that RxSight is subject to rigorous regulatory oversight by the Securities and Exchange Commission, requiring transparent quarterly financial reporting, public disclosures of earnings, and adherence to strict corporate governance standards that allow institutional and retail investors to buy and sell shares freely.